Search

Search results

4 results found

The miR-362-3p/BCLAF1 axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer

Publication: Journal Article

Liu, Zhaoji, Catherine Wu, Madison Uyemura, Brian R Sardella, Emily K Aronson, Shizhong Ke, Erica S Massicott, et al. 2026. “The MiR-362-3p/BCLAF1 Axis Regulates Cisplatin Sensitivity and Metastatic Progression in Triple-Negative Breast Cancer”. MedRxiv.

Genomic and Transcriptomic Landscape and Determinants of Response of BRCA-related Breast Cancers Treated with Neoadjuvant Chemotherapy (TBCRC 031)

Publication: Journal Article

Batalini, Felipe, Nadine Tung, Tae-Hee Clara Kim, Xanthi-Lida Katopodi, Nikolas Kalavros, Antuan Tran, Dimitra Karagkouni, et al. Submitted. “Genomic and Transcriptomic Landscape and Determinants of Response of BRCA-Related Breast Cancers Treated With Neoadjuvant Chemotherapy (TBCRC 031)”. Submitted, Submitted.

MicroRNA spatial profiling for assessing drug efficacy in BRCA1-related triple-negative breast tumors

Publication: Journal Article

Mohd, Omar N, Lin Wang, Brian R Sardella, David Jou, Gerburg M Wulf, Frank J Slack, Yujing J Heng, and Patrick S Doyle. 2026. “MicroRNA Spatial Profiling for Assessing Drug Efficacy in BRCA1-Related Triple-Negative Breast Tumors”. BioRxiv, 2026.01.12.698824.

AACR 2026 Meeting Abstracts

News: February 04, 2026

Dr. Heng will have 6 abstracts at AACR: Bockorny et al. Real-world evidence of KMT2C mutation as a biomarker of sensitivity to platinum-based therapy in solid cancers. (Oral) Liu et al. MiR-362-3p enhances platinum response in breast cancer. Guzman-Arocho et al. Associations of Stromal Markers with...